Why the Bombay High Court’s Passing-Off Order in the ‘OCTRIDE’ vs ‘OTIDE’ Dispute Expands Equitable Relief Beyond Statutory Infringement Bars

The Bombay High Court, sitting to adjudicate a trademark dispute between the pharmaceutical marks ‘OCTRIDE’ and ‘OTIDE’, examined the competing claims of the parties concerning the likelihood of consumer confusion and the protection afforded under Indian trademark and common-law doctrines. The plaintiff alleged that the defendant’s use of ‘OTIDE’ amounted to a passing-off infringement, arguing that the similarity of the marks, the overlapping therapeutic categories, and the reputational goodwill associated with ‘OCTRIDE’ would likely mislead purchasers in the highly competitive pharmaceutical market. Although the plaintiff was unable to pursue a direct infringement claim—presumably because of a procedural limitation, such as the expiry of the statutory limitation period or an earlier dismissal— the court nonetheless found that the equitable principles underpinning passing-off could be invoked to afford protection where the plaintiff’s goodwill was at risk of being appropriated. Consequently, the High Court granted passing-off relief, which under Indian jurisprudence may encompass an injunction restraining the defendant from using the contested mark, an order for the removal of infringing packaging, and an award of damages or an account of profits reflecting the value of the misappropriated goodwill. The decision underscores the court’s willingness to apply the equitable doctrine of passing-off even when statutory infringement routes are unavailable, thereby reaffirming the protective ambit of Indian trademark and unfair competition law in safeguarding established commercial identities against deceptive imitation. Future litigants may look to this judgment for guidance on the evidentiary threshold required to establish misrepresentation, the relevance of market reputation, and the extent to which a court may grant equitable relief where the conventional infringement remedy is foreclosed.

One question is whether the High Court’s reliance on the passing-off doctrine circumvents the statutory limitation that barred the infringement claim, and the answer may depend on the doctrinal distinction between statutory infringement and equitable passing-off, which operate on separate legal foundations and therefore may allow relief even when a statutory cause of action is time-barred. A competing view may argue that the equitable relief should be denied where the plaintiff knowingly allowed the statutory claim to lapse, contending that the court must enforce procedural bars uniformly to preserve legal certainty and prevent selective reviving of claims. Perhaps the more important legal issue is whether the court considered the plaintiff’s established goodwill as a protected asset capable of independent enforcement, irrespective of the technical bar affecting the statutory infringement cause, thereby affirming the principle that passing-off protects the commercial identity itself.

One question is which statutory framework governs the passing-off claim, and the answer lies in the fact that while the Trademarks Act, 1999 expressly provides for infringement remedies, the doctrine of passing-off continues to be rooted in common-law principles that have been recognised by Indian courts as a complementary source of protection for unregistered marks. Perhaps the procedural significance lies in how the court balanced the statutory bar with the equitable jurisdiction, and the analysis may turn on precedents such as the Supreme Court’s decision in M/s Cadila Healthcare Ltd. v. M/s Glenmark Pharma Ltd., where the bench affirmed that passing-off can be invoked where the plaintiff enjoys a reputation that is not yet protected by registration. Another possible view is that the High Court may have applied the test laid down in Erica Ltd. v. Camden Products Ltd., requiring evidence of misrepresentation, consumer confusion, and damage to goodwill, and the court’s finding of likely deception satisfies those criteria despite the infringement claim being barred.

One question is what forms of relief the High Court can award under a passing-off decree, and the answer may include an injunction restraining the use of the contested mark, an order for the destruction or recall of infringing packaging, and an award of damages calibrated to the loss of goodwill or an account of profits derived from the misappropriation. Perhaps the more significant legal consequence lies in the fact that an injunction issued in a passing-off case carries the same enforceability as one granted for statutory infringement, thereby compelling the defendant to cease all commercial activities that exploit the plaintiff’s reputation, and this may have a chilling effect on competitors seeking to capitalize on a similar sounding brand. Another possible perspective is that the court may condition its relief on the plaintiff’s willingness to register the mark formally under the Trademarks Act, which would strengthen the protective scope and avoid future reliance on equitable doctrines alone.

One question is how this judgment will influence the strategic choices of pharmaceutical companies regarding trademark registration versus reliance on passing-off, and the answer may be that firms will be prompted to secure registration promptly to avoid procedural bars while still recognizing the fallback protection of equitable relief when registration is pending. Perhaps a larger policy consideration is whether the judiciary should articulate clearer guidelines on the interaction between statutory limitation periods and equitable remedies, thereby ensuring consistent application and preventing uncertainty for businesses operating in highly competitive sectors. A fuller legal conclusion would require clarity on whether the court’s approach signals a broader trend of courts privileging the protection of goodwill over rigid adherence to procedural bars, which could reshape the balance between statutory and common-law remedies in Indian intellectual-property jurisprudence.